Showing results (1-10 of 300) with videos related to
Sort By:
Pageof 30
Cardiovascular Therapeutics|June 18, 2010
Review: Nutriceuticals as antithrombotic agentsSubrata Chakrabarti, Jane E FreedmanVascular Pharmacology|March 18, 2008
Dipyridamole, cerebrovascular disease, and the vasculatureSubrata Chakrabarti, Jane E FreedmanThe Journal of Biological Chemistry|April 27, 2007
CD40-40L signaling in vascular inflammationSubrata Chakrabarti, Price Blair, Jane E FreedmanJournal of Cardiovascular Pharmacology|December 1, 2007
Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effectsSubrata Chakrabarti, Price Blair, Cindy Wu, et al.Trends in Molecular Medicine|November 4, 2008
CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular diseaseMuhammad Rizvi, Didi Pathak, Jane E Freedman, et al.Thrombosis Research|February 22, 2008
Neutrophil CD40 enhances platelet-mediated inflammationPantila Vanichakarn, Price Blair, Cindy Wu, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 6, 2005
CD40 ligand influences platelet release of reactive oxygen intermediatesSubrata Chakrabarti, Sonia Varghese, Olga Vitseva, et al.The Journal of Pharmacology and Experimental Therapeutics|July 28, 2005
The effect of dipyridamole on vascular cell-derived reactive oxygen speciesSubrata Chakrabarti, Olga Vitseva, David Iyu, et al.Vascular Pharmacology|June 16, 2010
The role of CD40L and VEGF in the modulation of angiogenesis and inflammationSubrata Chakrabarti, Muhammad Rizvi, Kristine Morin, et al.Immunology Letters|February 4, 2009
Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cellsSubrata Chakrabarti, Muhammad Rizvi, Didi Pathak, et al.Pageof 30